Large scale production of pharma intermediates

New facility is being used to produce a greater range of pharmaceutical intermediates more quickly and cost effectively than was possible on conventional laboratory scale production equipment

Leading contract research company, Peakdale Molecular, recently invested in two large-scale glass reaction systems from Radleys to help upgrade the capabilities of its kilo laboratory.

The new facility is being used to produce a greater range of pharmaceutical intermediates more quickly and cost effectively than was possible on conventional laboratory scale production equipment.

In moving from laboratory scale to the 30 and 50 litre reactor systems, Peakdale design criteria covered issues including efficient heat exchange to cope with exothermic reactions and quenches; the ability to use the 50 litre system as a quench vessel for the smaller system and using gravity wherever practical to effect liquid transfer from vessel to vessel or rotary evaporator.

Radleys was able to help design and purpose-build the glass reaction systems to meet these specific and demanding requirements.

Radleys was also able to advise and provide the required heating/cooling units, an integral part of the reactor systems.

Following implementation, Radleys's after sales team responded quickly to requests to make modifications and repairs.

Radleys has established an international reputation as a leading supplier of high quality glass reaction vessels and systems.

Peakdale Molecular is a contract chemistry company specialising in design and synthesis of novel compounds for pharmaceutical research, in scales from a few milligrams to a few kilograms.

Back to top